These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1862460)

  • 21. Treatment of acute salpingitis--with special reference to Chlamydia trachomatis.
    Svensson L; Mårdh PA
    Scand J Infect Dis Suppl; 1982; 32():182-8. PubMed ID: 6958017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic therapy for pelvic inflammatory disease.
    Pastorek JG
    J Reprod Med; 1990 Mar; 35(3 Suppl):329-32. PubMed ID: 2181120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis).
    Peipert JF; Sweet RL; Walker CK; Kahn J; Rielly-Gauvin K
    Infect Dis Obstet Gynecol; 1999; 7(3):138-44. PubMed ID: 10371472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
    Judlin P; Koebele A; Zaccabri A; van Walleghen E; Pavis A; Badonnel Y; Dailloux M; Landes P
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):253-9. PubMed ID: 7622771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease.
    Soper DE; Despres B
    Obstet Gynecol; 1988 Jul; 72(1):7-12. PubMed ID: 3132668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole.
    Heinonen PK; Teisala K; Punnonen R; Aine R; Lehtinen M; Miettinen A; Paavonen J
    Genitourin Med; 1986 Aug; 62(4):235-9. PubMed ID: 3089909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin.
    Wasserheit JN; Bell TA; Kiviat NB; Wølner-Hanssen P; Zabriskie V; Kirby BD; Prince EC; Holmes KK; Stamm WE; Eschenbach DA
    Ann Intern Med; 1986 Feb; 104(2):187-93. PubMed ID: 3004276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
    Hemsell DL; Wendel GD; Gall SA; Newton ER; Gibbs RS; Knuppel RA; Lane TW; Sweet RL
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
    Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medical management of chronic Chlamydia trachomatis salpingitis resistant to usual antibiotics. Use of ofloxacin alone or combined with other anti-chlamydia antibiotics].
    Henry-Suchet J; Tannous W
    Contracept Fertil Sex; 1993 Sep; 21(9):627-9. PubMed ID: 8261008
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antibiotic therapy in the treatment of inflammatory diseases in the minor pelvis].
    Vasiljević M; Marković A; Ganović R; Jovanović R
    Srp Arh Celok Lek; 1996; 124(7-8):193-6. PubMed ID: 9102846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute pelvic inflammatory disease: comparison of therapeutic protocols].
    Balbi G; Piscitelli V; Di Grazia F; Martini S; Balbi C; Cardone A
    Minerva Ginecol; 1996; 48(1-2):19-23. PubMed ID: 8750486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens.
    Sochalski A; Sullman S; Andriole VT
    Am J Surg; 1988 May; 155(5A):96-101. PubMed ID: 3132048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic abortion and Chlamydia trachomatis infection.
    Qvigstad E; Skaug K; Jerve F; Vik IS; Ulstrup JC
    Br J Vener Dis; 1982 Jun; 58(3):182-3. PubMed ID: 6805851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations and rationale for the treatment of pelvic inflammatory disease.
    Jaiyeoba O; Lazenby G; Soper DE
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):61-70. PubMed ID: 21171878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.
    Mugo NR; Kiehlbauch JA; Nguti R; Meier A; Gichuhi JW; Stamm WE; Cohen CR
    Obstet Gynecol; 2006 Apr; 107(4):807-12. PubMed ID: 16582116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease.
    Miettinen A; Laine S; Teisala K; Heinonen PK
    Arch Gynecol Obstet; 1991; 249(2):95-101. PubMed ID: 1953057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis.
    Mogabgab WJ; Holmes B; Murray M; Beville R; Lutz FB; Tack KJ
    Chemotherapy; 1990; 36(1):70-6. PubMed ID: 2307026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
    Heinonen PK; Leinonen M
    Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvic inflammatory disease. Key treatment issues and options.
    Peterson HB; Walker CK; Kahn JG; Washington AE; Eschenbach DA; Faro S
    JAMA; 1991 Nov; 266(18):2605-11. PubMed ID: 1658404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.